Centre Hospitalier Universitaire de Nice
chu-nice.frLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
700
Active
203
Phase 3
29
Total enrollment
158,279
Pipeline matrix
Showing 40 of 51 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Botulinum toxin | — | — | — | — | — | 1 | |
| Verapamil | — | — | — | — | — | 1 | |
| Experimental: dose binding arm | — | — | — | — | — | 1 | |
| Active Comparator: traditionnal arm: Weight-based dosing | — | — | — | — | — | 1 | |
| Empagliflozin 10 MG then Placebo | — | — | — | — | — | 1 | |
| oxygenotherapy | — | — | — | — | — | 1 | |
| Efgartigimod | — | — | — | — | — | 1 | |
| Administration of METHOXYFLURANE | — | — | — | — | — | 1 | |
| Standard of care | — | — | — | — | — | 1 | |
| Fluid resuscitation with isotonic saline only | — | — | — | — | — | 1 | |
| Fluid resuscitation with Ringer Lactate | — | — | — | — | — | 1 | |
| Rituximab | — | — | — | — | 2 | ||
| amoxicillin or moxifloxacin | — | — | — | — | — | 1 | |
| amoxicillin or moxifloxacin + rifampicin | — | — | — | — | — | 1 | |
| OXYGENE MEDICINAL LIQUIDE AIR PRODUCTS MEDICAL | — | — | — | — | — | 1 | |
| Ocrelizumab | — | — | — | — | — | 1 | |
| ISOtretinoin 5 MG | — | — | — | — | — | 1 | |
| Topical cream | — | — | — | — | — | 1 | |
| Methotrexate Injectable Solution | — | — | — | — | — | 1 | |
| Deucravacitinib | — | — | — | — | — | 2 | |
| Amiloride | — | — | — | — | — | 1 | |
| Placebos | — | — | — | — | — | 1 | |
| Upadacitinib | — | — | — | — | — | 1 | |
| Bimekizumab | — | — | — | — | — | 1 | |
| Clobetasol | — | — | — | — | — | 1 | |
| Apremilast treatment | — | — | — | — | — | 1 | |
| Satralizumab Prefilled Syringe | — | — | — | — | — | 1 | |
| Tirbanibulin | — | — | — | — | — | 1 | |
| LITFULO | — | — | — | — | — | 1 | |
| Cytarabine and Idarubicin | — | — | — | — | — | 1 | |
| CPX-315 | — | — | — | — | — | 1 | |
| Forxiga | — | — | — | — | — | 1 | |
| SKYCLARYS | — | — | — | — | — | 1 | |
| Evaluation of cytokine production | — | — | — | — | — | 1 | |
| capillary blood sampling | — | — | — | — | — | 1 | |
| supplementary tubes | — | — | — | — | — | 1 | |
| Specific blood samples | — | — | — | — | — | 1 | |
| Premature neonates with invasive infection caused by Bacillus cereus | — | — | — | — | — | 1 | |
| CYSCONTROL/PHYTOCYST Herbal tea | — | — | — | — | — | 1 | |
| Guselkumab | — | — | — | — | — | 1 |
11 more active programs hidden
Next readouts
- 2022-03-07
- 2023-04-01
- 2023-06-20
- 2025-04
- 2025-05-15
- 2025-09-05
- 2025-09-30
- 2025-10-01
- 2025-12-05
- 2026-02-01
Top conditions
- Alzheimer Disease13
- Multiple Sclerosis12
- Vitiligo12
- Obesity8
- Alzheimer's Disease8
- Osteoporosis7
- COVID7
- Rheumatoid Arthritis7
Frequently asked questions about Centre Hospitalier Universitaire de Nice
- How many clinical trials does Centre Hospitalier Universitaire de Nice have on ClinicalTrials.gov?
- Centre Hospitalier Universitaire de Nice is listed as the lead sponsor on 700 clinical trials in ClinicalTrials.gov, 203 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Centre Hospitalier Universitaire de Nice's trials are in Phase 3?
- 29 of Centre Hospitalier Universitaire de Nice's trials are in Phase 3, spread across 51 active drug programs.
- What therapeutic areas does Centre Hospitalier Universitaire de Nice focus on?
- Centre Hospitalier Universitaire de Nice's most-studied conditions on ClinicalTrials.gov are Alzheimer Disease, Multiple Sclerosis, Vitiligo, Obesity, Alzheimer's Disease.
- When are Centre Hospitalier Universitaire de Nice's next clinical trial readouts?
- Centre Hospitalier Universitaire de Nice has 10 upcoming primary-completion readouts tracked here; the soonest is “MITOMICS : a Multi-OMICS Approach for the Diagnosis of Mitochondrial Diseases”, expected around 2022-03-07.